Buy or sell Reven Pharmaceuticals stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Reven Pharmaceuticals Stock


About Reven Pharmaceuticals Stock

Reven Pharmaceuticals, Inc. is a development-stage bio-pharmaceutical company that develops and markets propriety solutions for the treatment of cardiovascular and circulatory related conditions. These non-surgical, minimally invasive treatments have shown to improve vascular function and circulation without invasive medical procedures, such as atherectomy or balloon angioplasty and stents.

Funding History

January 2014$1.8M
February 2015$4.4M
January 2016$10.0M
January 2017$23.0M
January 2019$23.0M


Co-Founder & Chief Executive Officer

Peter Lange

Chief Financial Officer

Michael Volk

Chief Operating Officer

Brian Denomme

Chief Technology Officer

James Ervin

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Reven Pharmaceuticals or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: